Making the Match

A soon-to-launch service from a company called GenePeeks is to use microarrays to examine the genomes of both sperm bank clients and donors to uncover possible genetic disease risk, reports MIT's Technology Review. Tech Review notes that sperm bank donors currently are screened for a few genetic diseases, like cystic fibrosis, but GenePeeks aims to look at a wider swath.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Health Preview

Don't Chew The Pills!

Three-Person IVF

This Week in PNAS

The Baby's Sequence

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.